Glioblastoma exhibits profound intratumoral heterogeneity in blood perfusion, which may cause inconsistent therapy response. Particularly, low perfusion may create a hypoxic microenvironment and induce resistant clones. Thus, developing validated imaging approaches that define low perfusion compartments is crucial for clinical management.
Introduction
Glioblastoma is a highly aggressive primary tumor in the central nervous system of adults (Weller et al., 2017) . Despite advances in treatment, the median overall survival (OS) of glioblastoma patients remains low at 14.6 months (Stupp et al., 2005) . Inconsistent response to treatment is a major challenge in glioblastoma treatment stratification and could be caused by the extensive heterogeneity of this disease. Many genetically distinct cancer cell populations can exist in the same tumor and display diverse treatment response (Sottoriva et al., 2013; Verhaak et al., 2010) . Developing validated methods to explore intratumoral heterogeneity is crucial for patient subgrouping and personalized treatment.
One of the most fundamental traits of glioblastoma is chronic angiogenesis and elevated perfusion, associated with a more invasive phenotype (Hanahan & Weinberg, 2011; Lathia, Heddleston, Venere, & Rich, 2011) . However, a potent angiogenesis inhibitor failed to demonstrate consistent benefits in clinical trials of de novo glioblastoma (Chinot et al., 2014) . A possible explanation for this failure is the profound intratumor perfusion heterogeneity observed in glioblastomas, which is due to aberrant microvasculature and inefficient nutrient delivery. This heterogeneity can give rise to regions in the tumor where the demand and supply of nutrients is mismatched (Komar et al., 2009) . Consequently, the sufficiently perfused sub-regions may hold the advantages for progression and proliferation, whereas the insufficiently perfused sub-regions may have a hypoxic microenvironment (Gillies, Schornack, Secomb, & Raghunand, 1999) . The selective stress created thereafter could impact clonal evolution (Quail & Joyce, 2013) , and preferentially induce adaptive and treatment resistant clones (Pistollato et al., 2010) .
Here we describe a method for identifying low perfusion compartments in glioblastoma using multiparametric physiological magnetic resonance imaging (MRI), which allows a more comprehensive evaluation of tumor physiology compared to the morphological heterogeneity visualized by structural MRIs. Our approach improves on current clinical practice, which can lead to non-specific results by inferring low perfusion sub-regions as nonenhancing regions within an otherwise contrast enhancing volume on post-contrast T1weighted structural images (O'Connor et al., 2015) .
The two low perfusion compartments we visualized have distinct cellularity: one compartment with increased cellularity representing a population adapted to hypoxic acidic conditions (Gatenby, Grove, & Gillies, 2013) , and one compartment with low cellularity representing a necrotic region. By combining perfusion and diffusion imaging we studied the metabolic interplay between supply and demand of nutrients in each compartment. Using multivariate survival analysis, we demonstrate that the volume and lactate level of these two compartments are clinically important.
Results

Multiparametric MRI identifies two low perfusion compartments. A total of 112 patients
were included in the study (mean age 59.4 years, range 22-76, 84 males; Overview: Table 1; Study design and patient recruitment: Figure S1 ). Each patient was imaged using dynamic susceptibility contrast-enhanced (DSC) MRI to measure perfusion, diffusion tensor imaging (DTI) to measure diffusion and 1 H magnetic resonance spectroscopy (MRS) chemical shift imaging to measure levels of metabolites. T2-weighted MRI was acquired for anatomical reference. T2-weighted fluid attenuated inversion recovery (FLAIR) images and post-contrast T1-weighted images were acquired to assess the extent of the tumor. The full imaging protocol as well as image post-processing is described in the Methods section. Tumor regions of interest (ROIs) were manually drawn on the post-contrast T1-weighted images and on FLAIR, indicating the solid tumor and the infiltrative regions, respectively. The volumes of each ROI for different patient subgroups is shown and compared in Table 1 . As a normal control, ROIs were also drawn on normal-appearing contralateral white matter (NAWM).
Apparent diffusion coefficient (ADC) and relative cerebral blood volume (rCBV) values were obtained from each voxel within the contrast-enhancing (CE) ROI delineated on the post-contrast T1-weighted images , and low perfusion regions were identified by the lowest quartile of the pooled rCBV values (rCBV L ) as shown in Figure   1 . The lowest (ADC L ) and highest quartiles (ADC H ) of the ADC maps were overlaid on the rCBV L maps, defining a tumor compartment with low perfusion and restricted diffusion (ADC L -rCBV L ) and a compartment with low perfusion and high diffusion (ADC H -rCBV L ). Figure 2 (A, D) shows the two compartments for two different tumors. The procedure for identifying these two compartments is illustrated in Figure 1 , and Table 1 shows the volume of each compartment for different patient subgroups. The ADC H -rCBV L compartment (volume 5.7 ± 4.6 cm 3 ) was generally larger than the ADC L -rCBV L compartment (volume 2.3 ± 2.2 cm 3 ) (P < 0.001). Completely resected tumors had smaller CE volume (P = 0.006) and smaller ADC H -rCBV L compartment (P = 0.002). Other regions within the contrast-enhancing ROI but outside the two selected compartments were utilized as abnormal controls (CE control, CEC). Low perfusion compartments displayed hypoxic and pro-inflammatory metabolic signatures. MRS was used to further assess the metabolism in each tumor sub-region for patients with sufficient overlap between the low perfusion regions and the region examined by MRS (we refer to Methods for analysis details). We measured the lactate (Lac) and macromolecule and lipid levels at 0.9 ppm (ML9) in the spectra, as an increase in Lac is frequently detected in hypoxic microenvironments, while ML9 was recently associated with pro-inflammatory microglial response to immune stimulus (Pardon et al., 2016) .
The low perfusion and high diffusion compartment ADC H -rCBV L showed a significantly higher lactate/creatine (Lac/Cr) ratio than NAWM (P < 0.001), as well as an increased ML9/Cr ratio compared to NAWM (P < 0.001). Similarly, the ADC L -rCBV L compartment displayed higher Lac/Cr ratio and ML9/Cr ratio than NAWM (both P < 0.001).
Although not significant, the Lac/Cr and ML9/Cr ratios in the ADC H -rCBV L compartment were higher than the ADC L -rCBV L compartment (Table S1 ). Figure 2 shows overlays between the rCBV-ADC compartments and the MRS voxels for two example cases, as well as the metabolite levels in each ROI and compartment.
The contrast-enhancing (CE) tumor volume was significantly correlated with the Lac/Cr ratio in the ADC L -rCBV L (P = 0.018, rho = 0.34), indicating that this compartment had higher lactate level in tumors with a larger CE volume. Interestingly, the volume of tumor infiltration beyond contrast enhancement, which was delineated on FLAIR images and normalized by CE volume, showed a moderate positive correlation with the proportional volume of the ADC L -rCBV L compartment (P < 0.001, rho = 0.42) and a negative correlation with the proportional volume of the ADC H -rCBV L compartment (P < 0.001, rho = -0.32).
This indicated that tumors with a large infiltrative volume tended to have smaller ADC H -rCBV L and larger ADC L -rCBV L compartments. The correlations of ROI volumes are demonstrated in Figure S2 . 
The low perfusion low diffusion compartment of Minimally invasive tumors is less hypoxic.
To further explore the relation between hypoxic compartments and tumor invasiveness, we investigated diffusion tensor imaging (DTI) based invasive phenotypes of 64 patients overlapping with a previously reported cohort . DTI measures directional diffusion, and is a sensitive method to detect the subtle white matter disruption caused by tumor infiltration (Price et al., 2007) . By decomposing the diffusion tensor into isotropic (p) and anisotropic components (q), three invasive phenotypes of glioblastoma have previously been defined (minimal, localized, and diffuse, illustrated in Figure S3 ), and correlated to patient outcomes and isocitrate dehydrogenase (IDH) mutation status, a prognostic driver mutation of gliomas. The minimally invasive phenotype displayed a lower volume of ADC L -rCBV L compartment than the localized (P = 0.031) and diffuse phenotype (not significant), and a higher volume of ADC H -rCBV L compartment than the localized (P = 0.024) and diffuse phenotype (not significant), suggesting the contributions of the two low perfusion compartments to tumor invasiveness were different. Of note, the minimally invasive phenotype displayed lower Lac/Cr ratio compared to the localized (P = 0.027) and diffuse phenotype (P = 0.044), indicating that the ADC L -rCBV L compartment experienced less hypoxic stress in the minimally invasive tumors. A full comparison between the three invasive phenotypes can be found in Table S2 .
Low perfusion compartments exhibited diversity in contribution to treatment response.
We analyzed the available survival data of 80 patients, who received maximal surgery followed by standard regimen of radiotherapy with concomitant temozolomide (TMZ) chemotherapy followed by adjuvant TMZ chemotherapy. The median progression-free survival (PFS) of these patients was 265 days (range 25-1130 days) and overall survival was 455 days (range 52-1376 days).
First, we used multivariate Cox regression to analyse all the relevant clinical factors.
The results showed that extent of resection (EOR) (PFS: hazard ratio [HR] = 2.825, P = 0.003; OS: HR = 2.063, P = 0.024), CE tumor volume (OS: HR = 2.311, P < 0.001) and FLAIR tumor volume (OS: HR = 0.653, P = 0.031) significantly affected survivals.
Next, we included the volumes of two compartments and their weighed average Lac/Cr ratios into the survival models. We used a stepwise procedure to select all prognostic variables. The results showed that higher volumes of the two compartments contributed to better PFS (ADC H -rCBV L : HR = 0.102, P = 0.049; ADC L -rCBV L : HR = 0.184, P = 0.033), whilst the higher Lac/Cr ratio in the two compartments contributed to worse PFS (ADC H -rCBV L : HR = 6.562, P = 0.002; ADC L -rCBV L : HR = 2.995, P = 0.047). Further, the higher Lac/Cr ratio in the ADC L -rCBV L compartment also significantly contributed to worse OS (HR = 4.974, P = 0.005). In contrast, the Lac/Cr ratio in the contrast-enhancing control regions contributed to better survivals (PFS: HR = 0.053, P = 0.001; OS: HR = 0.090, P = 0.007). The results of the Cox proportional hazards models are described in Table 2 and the Kaplan-Meier survival curves with log-rank test are shown in Figure 3 . 
Discussion
This study combined perfusion and diffusion related parameters to define sub-regions of glioblastoma tumors. The two identified low perfusion compartments displayed distinct response to treatment, compared to contrast-enhancing tumor regions. This finding is consistent with recent studies suggesting various adaptive phenotypes exist under selective pressure and can predict patient survival (Zhou et al., 2016) . As far as we know, this is the first study using pretreatment physiological MRI to identify these compartments non-invasively, which may provide crucial information for the determination of tumor invasiveness in clinical decision.
The clinical values of the individual image derived parameters have been extensively assessed previously and are supported by our findings. Among them, rCBV is associated with tumor angiogenesis and proliferation, and has recently been found to indicate IDH mutation status, associated with hypoxia-initiated angiogenesis (Kickingereder et al., 2015) . Decreased ADC is thought to represent higher tumor cellularity and cell packing (Chen et al., 2013) and has been associated with shorter survival (Shiroishi, Boxerman, & Pope, 2016) . However, it remained unknown if integrating these markers could visualize clinically relevant intratumor habitats. We identified two low perfusion compartments with confirmed hypoxic stress demonstrated by elevated lactate levels compared to normal and abnormal controls. With similar perfusion levels in these two compartments, the higher cellularity (ADC L ) in the ADC L -rCBV L compartment suggests that this compartment may display a higher degree of mismatch between supply and demand of nutrients. The elevated ML9/Cr ratios may suggest both compartments displayed elevated inflammation response (Pardon et al., 2016) , potentially due to recruitment of tumor-promoting inflammatory cells by necrotic cells (Aktipis, Boddy, Gatenby, Brown, & Maley, 2013; Galluzzi & Kroemer, 2008) .
The positive correlation between contrast-enhancing tumor volume and Lac/Cr ratios in the ADC L -rCBV L compartment could indicate an acquired hypoxic microenvironment as the solid tumor grows. When evaluating the non-enhancing regions surrounding the solid tumor, we found that tumors with large infiltrative volume tended to have smaller ADC H -rCBV L and larger ADC L -rCBV L compartments, suggesting that the latter compartment might be more responsible for tumor infiltration. This was supported by our findings that minimally invasive phenotypes displayed significantly lower lactate levels in the ADC L -rCBV L compartment.
We further investigated the contributions of the two compartments to patient survivals in a cohort who have received standard dose of concurrent temozolomide (TMZ) chemoradiotherapy followed by adjuvant TMZ after surgery. Interestingly, a higher Lac/Cr ratio in the two compartments was related to worsened outcomes (HR > 1) while this ratio in other contrast-enhancing tumor regions showed a reduced hazard (HR < 1). This suggests that the resistant phenotypes induced by hypoxia mainly nest in the two identified compartments.
As the ADC L -rCBV L compartment was correlated to tumor infiltration area, diffusion invasiveness, and significantly contributed to both PFS and OS, this compartment may be more responsible for treatment resistance. Additionally, we found that the volumes of both compartments significantly contributed to better survivals in the multivariate model, while the Lac/Cr ratios contributed to worse survivals. These results suggested that the extent of low perfusion, indicated by the volume, and the intensity of hypoxia, indicated by the lactate level, have different clinical implications. Specifically, the higher proportion of the low perfusion compartments may represent a relatively lower proliferative phenotype, while the more intensive hypoxia in these compartment may represent a more aggressive phenotype.
Our findings have clinical significance, as they can help targeting treatment to the selective pressure within tumors. As radiotherapy and chemotherapy can cause selective stress, our identification of possibly resistant target regions could inform the choice of treatment. Additionally, several recent studies postulated that antiangiogenic agents failed to demonstrate consistent response because they can induce the adaptive clones and thus cause treatment resistance (Hu et al., 2012; Liu et al., 2016) . Our findings of the two low perfusion compartments may provide indications for selection of antiangiogenic therapy. Particularly, we suggest more attention might be needed for patients with larger volumes of ADC L -rCBV L compartment when considering antiangiogenic agents. The possibility of aggravating hypoxia in this compartment may lead to a more aggressive phenotype.
There are some limitations in our study. While the number of included patients is fairly large, this was a single cohort study. Due to the limited MRS spatial resolution, the multivariate analysis was based on only a subset of the patient cohort. Similarly, the survival analyses were based on the subset of patients who received standard chemoradiotherapy following surgery. The cut-off values defining the two compartments were based on the upper and lower quartiles of the rCBV and ADC distributions, rather than optimizing for threshold specifically. Lastly, although our imaging markers are well validated histologically from other studies (Price et al., 2006) , full biological validation can only be achieved with multi-region sampling of each tumor.
In conclusion, we showed that multiparametric imaging could identify two low perfusion compartments displaying heterogeneity in extent and intensity of hypoxia, and consequently exhibiting diversity in tumor invasion and treatment response. The findings in our study may help optimize the current clinical routine which is mainly based on nonspecific conventional imaging. The compartment demonstrating both low perfusion and restricted diffusion may indicate a habitat resistant to adjuvant therapies that may aggravate the hypoxic stress. This could provide crucial information for treatment choice in a personalized treatment setting. As our analyses were based on clinically available imaging modalities, this approach could easily be implemented, and potentially extended to other tumor sites. analyzed for overall and progression-free survival. The latter was in all follow-up cases made retrospectively to avoid the issue of pseudoprogression. All patients were followed up according to the criteria of response assessment in neuro-oncology (RANO) (Wen et al., 2010) . Seven of 112 (6.3%) patients had the IDH-1 R132H mutation and 105 of 112 (93.8%) patients were IDH-1 wild type. MGMT-methylation status was available for 108 patients, among which 48 (44.4%) patients were methylated. This study was approved by local institutional review board, and informed written consent was obtained from all patients. Image processing. For each subject, all MRI images were co-registered to T2-weighted images with an affine transformation, using the linear image registration tool (FLIRT) functions (Jenkinson, Bannister, Brady, & Smith, 2002) in Oxford Centre for Functional MRI of the Brain (FMRIB) Software Library (FSL) v5.0.0 (Oxford, UK) (Smith et al., 2004) . DSC data were processed and leakage correction was performed using NordicICE (NordicNeuroLab, Bergen, Norway) . The arterial input function was automatically defined and rCBV was calculated in NordicICE. DTI images were processed with a diffusion toolbox (FDT) in FSL (Behrens et al., 2003) , during which normalization and eddy current correction were performed. The isotropic component (p) and anisotropic component (q) were calculated using the equation as previously described (Pena et al., 2006) . MRS data were processed using LCModel (Provencher, Oakville, Ontario) and the concentrations of lactate (Lac) and macromolecule and lipid levels at 0.9 ppm (ML9) were calculated as a ratio to creatine (Cr).
Methods
All relevant spectra from MRS voxels of interest were assessed for artefacts using previously published criteria (Price et al., 2016) . The values of the Cramer-Rao lower bounds were used to evaluate the quality and reliability of MRS data and values with standard deviation (SD) > 20% were discarded (Price et al., 2016) .
Regions of interest and volumetric analysis.
Tumor Regions of interest (ROIs) were manually drawn using an open-source software 3D slicer v4.6.2 (https://www.slicer.org/) (Fedorov et al., 2012) by a neurosurgeon with > 7 years of experience (××) and a researcher with > 4 years of brain tumor image analysis experience (××) and reviewed by a neuroradiologist with > 8 years of experience (××) on the post-contrast T1WI and FLAIR.
The interrater variability of the ROIs showed good agreement between the two raters, with Dice similarity coefficient scores of 0.85 ± 0.10 (CE) and 0.86 ± 0.10 (FLAIR) respectively.
For each individual patient, ROIs of normal-appearing white matter (NAWM) were drawn with the same method in the contralateral white matter as a normal control. All images were normalized by the mean value in NAWM. Further processing was done using MATLAB (v2016a, The MathWorks, Inc., Natick MA).
Firstly, ADC and rCBV values were obtained from each voxel within the contrastenhancing (CE) ROI delineated on the post-contrast T1-weighted images and pooled together as described previously . The lowest quartile of the pooled rCBV values (rCBV L ) were interpreted as low perfusion regions. Then the first quartile (ADC L ) and last quartile (ADC H ) of ADC map were respectively overlaid on rCBV L maps. Finally, two intersections of ADC L -rCBV L and ADC H -rCBV L ROIs were obtained (Figure 1 ). Other regions within CE outside the two ADC-rCBV ROIs were taken as abnormal controls (CE control, CEC). Raw volumes of ROIs were calculated using the function of fslmaths in FSL (Smith et al., 2004) . Proportional volumes (%) of two ADC-rCBV ROIs were calculated as the ratio of the raw volumes to CE volume.
Multivoxel MRS processing. Due to the difference in spatial resolution between MRS and MRI, voxels from T2-weighted MRIs were projected onto MRS according to their coordinates using MATLAB. Thus, the metabolic status in each voxel could be matched to the voxels in the MRI derived physiological maps, which were coregistered to T2-weighted images. The proportion of T2-space tumor voxels occupying each MRS voxel was calculated, and only those MRS voxels that were completely within the delineated tumor were included in further analyses. The weight of each MRS voxel was taken as the proportion of the ADC-rCBV compartments in that MRS voxel. The weighted sum value was used as final metabolic value of the tumor ROI. This method provides an objective method for MRS voxel selection. Left: the selection criteria. The T2-space pixels are projected to MRS space according to their coordinates. The proportion of T2-space tumor pixels occupying each MRS voxel is calculated. A criterion is applied that only those MRS voxels are included when this voxel is completely within delineated tumor. In this case, grid 1-6 met the criteria. A weighted average metabolite content for each region is calculated from the metabolite content of each voxel within it weighted by that voxel's percentage of (ADC H -rCBV L [blue]: grid 1,2 and 4 are counted; ADC L -rCBV L [yellow], grid 3 and 5 are counted; abnormal control [CEC]: grid 1-6 are counted). Right: Example spectra of ROIs. Each spectrum corresponds to the grids on the left. Grid 2: lactate/Cr ratio 13.2, ML9/Cr ratio: 10.4; grid 3: lactate/Cr ratio 28.4, ML9/Cr ratio: 22.7; grid 6: lactate/Cr ratio 8.9, ML9/Cr ratio: 16.6; grid 7 (NAWM): lactate/Cr ratio 0.37, ML9:1.36.
Statistical analysis.
All analyses were performed with RStudio v3.2.3. Continuous variables were tested with Welch Two Sample t-test. MRS data or tumor volume, were compared with Wilcoxon rank sum test or Kruskal-Wallis rank sum test (multiple comparisons), using Benjamini-Hochberg procedure for controlling the false discovery rate in multiple comparisons. Spearman rank correlation was used to model the relation between the volume of two ADC-rCBV ROIs and the volume of CE and FLAIR ROIs. Kaplan-Meier and Cox proportional hazards regression analyses were performed to evaluate patient survival. For the Kaplan-Meier analysis, the volumes of ROIs and MRS variables were dichotomized for OS and PFS before the log-rank test using optimal cutoff values calculated by the function of 'surv_cutpoint' in R Package "survminer". Patients who were alive at the last known follow-up were censored. To test the contribution of the intensity of hypoxia (measured by Lac/Cr ratio) to patient survival, multivariate Cox regression with forward and backward stepwise procedures was performed for the selection of prognostic variables. The forward procedure initiated from the model which only contained one covariate. The backward procedure initiated from the model in which all covariates were included. For each step, the model obtained after adding or deleting one covariate was evaluated using the Akaike Information Criterion (AIC). The final multivariate Cox regression model was constructed using only the features selected by the stepwise procedures. Significance was accepted at a two-sided significance level of alpha < 0.05.
